Login / Signup

Divergent RET - and BRAF -Mediated Resistance to Osimertinib in EGFR -Mutant NSCLC: A Case Report.

Muneeb RehmanChul KimJoshua E ReussLesli A KiedrowskiRavin J GargStephen V Liu
Published in: JCO precision oncology (2022)
Keyphrases
  • small cell lung cancer
  • wild type
  • epidermal growth factor receptor
  • advanced non small cell lung cancer
  • brain metastases
  • tyrosine kinase
  • metastatic colorectal cancer